Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Indonesia Journal Of Pharmacy
Novtafia Endri
College of Pharmaceutical Science, Riau- Indonesia
Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Rasionalitas Antibiotik Pasien Bronkitis Akut Anak Dengan Metode Gyssens Di RSIA Zainab Kota Pekanbaru Endri, Novtafia; Rahmawati, Ayu; Rahmawati, Noveri; Nesya, Nabilla Fadhia
The Journal Of Pharmacy Vol. 1 No. 1 (2023): Journal Of Pharmacy UMRI
Publisher : LPPM, Universitas Muhammadiyah Riau

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

According to WHO, as many as 13 million children in the world die every year and most of these deaths are in developing countries, where ISPA is one of the main causes of death by killing as many as 4 million children each year. Bronchitis ranks 6th out of 10 causes of death. However, Indonesia still has no reports on exact figures regarding this disease. This study aims to determine the accuracy of the use of antibiotics in pediatric patients with acute bronchitis based on the Gyssens method at RSIA Zainab Pekanbaru City. This type of research was non-experimental with data collection using a purposive sampling technique retrospectively. The results of the study based on a qualitative evaluation of the use of antibiotics in pediatric acute bronchitis patients at RSIA Zainab Pekanbaru City using the Gyssens method showed the quality of rational use of antibiotics found that 64 patients were declared rational ( category 0) and 5 patients were declared irrational. If possible further research regarding the rationality of using antibiotics in pediatric acute bronchitis patients at RSIA Zainab Pekanbaru City can be carried out using the DDD method or with a prospective approach so that monitoring of the patient's condition progress can be carried out from day to day.
17-2 Analisis Perbandingan Biaya Riil dan Tarif Ina-Cbg’s pada Pasien Rawat Jalan Onkologi dengan Terapi Morfin Sulfat (Mst) di RSUD Arifin Achmad Provinsi Riau Meirita, Efilia; Endri, Novtafia; Hari, Dewi Gulyla; Lifiani, Rialita
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 17 No. 2 (2025): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Health service financing through the INA-CBG's (Indonesia Case-Based Groups) system aims for efficiency and transparency in the National Health Insurance (JKN) system. However, in practice, there are often discrepancies between INA-CBG's rates and the real costs incurred by health facilities, especially in oncology patients with Morphine Sulfate (MST) therapy. This study aims to analyze the comparison of real costs and INA-CBG's tariffs for oncology outpatients with morphine sulfate therapy (MST) at RSUD Arifin Achmad Riau Province. This study used descriptive observational research method with retrospective data collection obtained from medical records of oncology outpatients who received Morphine Sulfate (MST) therapy 10 mg and 15 mg tablets during the period January-March 2024. The data were analyzed by comparing the real costs incurred by the hospital with the rates paid by BPJS through the INA-CBG's system and the Mann-Whitney U test was performed. The results of the analysis showed that there was a significant difference between real costs and INA-CBG's tariffs. The average real cost of drugs (MST) was higher than the INA-CBG's tariff. The real cost of drugs that exceeded the INA-CBG's tariff amounted to 481 people, with a total cost difference (loss) of IDR 218,155,324. There was a difference between real costs and INA-CBG's rates (p = .047) and INA-CBG's rates (p = .113).
Co-Authors AYU RAHMAWATI Hari, Dewi Gulyla Lifiani, Rialita Meirita, Efilia Nesya, Nabilla Fadhia Noveri Rahmawati